Clinical Science
 1987
DOI: 10.1042/cs073038pa
|View full text |Cite
|
Sign up to set email alerts
|

Rs-43285 (Syntex) A Preliminary Study of A Unique Anti-Anginal Agent

Diwakar Jain
1
,
Avijit Lahiri
2
,
P Dasgupta
3
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
1

Year Published

1994
1994
2012
2012

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
0
1
Order By: Relevance
“…8 Our results failed to confirm these published data. We conclude that therapy with ranolazine 30, 60, and 120 mg tid is not superior to placebo therapy.…”
Section: Plasma Ranolazine Concentrationcontrasting
confidence: 57%

Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.

Thadani
1
,
Ezekowitz
2
,
Fenney
3
et al. 1994
Circulation
69
1
52
0
View full textAdd to dashboardCite
“…8 Our results failed to confirm these published data. We conclude that therapy with ranolazine 30, 60, and 120 mg tid is not superior to placebo therapy.…”
Section: Plasma Ranolazine Concentrationcontrasting
confidence: 57%

Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.

Thadani
1
,
Ezekowitz
2
,
Fenney
3
et al. 1994
Circulation
69
1
52
0
View full textAdd to dashboardCite

Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal

Thadani1
2012
Expert Opinion on Pharmacotherapy
12
0
4
0
View full textAdd to dashboardCite
show abstract
scite logo

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product
Browser ExtensionAssistant by sciteCitation Statement SearchReference CheckVisualizationsDashboardsExplore JournalsExplore OrganizationsExplore FundersEmbedding BadgeEmbedding Citation SearchPricing
Resources
BlogHelp & FAQAccessibility StatementAPI TermsFor Universities & GovernmentsFor ResearchersFor PublishersFor Corporate, Pharma & EnterpriseAuthor MarketingBecome an AffiliateGet an organization trial or quotescite Data & Services
About
News & PressCareersRead our PaperCoverage

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BlogTerms and ConditionsAPI TermsPrivacy PolicyContactCookie PreferencesDo Not Sell or Share My Personal Information

Copyright © 2025 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.